Skip to main content
TipRanks
Go Ultimate75% OFF

BridgeBio Oncology Therapeutics (BBOT) Balance Sheet

79 Followers

BridgeBio Oncology Therapeutics Balance Sheet

BridgeBio Oncology Therapeutics's total assets for Q3 2026 were $346.22M, a decrease of 8.09% from the previous quarter. BBOT total liabilities were $52.84M for the fiscal quarter, a 1.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 448.38M$ 194.42M$ 332.89K$ 144.58K$ 144.28K
$ 37.28M$ 5.71M$ 396.46K$ 166.46K$ 162.64K
$ 411.10M$ 188.72M$ -63.57K$ -21.88K$ -18.36K

Currency in USD

BridgeBio Oncology Therapeutics Liabilities to Assets

0200M400M600M0 %50 %100 %150 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets